Vermillion & White Wealth Management Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-77
Closed -$5.18K 251
2025
Q4
$5.18K Hold
77
﹤0.01% 407
2025
Q3
$5.65K Hold
77
﹤0.01% 395
2025
Q2
$4.01K Buy
77
+3
+4% +$171 ﹤0.01% 423
2025
Q1
$4.72K Buy
+74
New +$4.3K ﹤0.01% 360

Other funds holding HALO

Vermillion & White Wealth Management Group's HALO Position: Q1 2026 in Review

Vermillion & White Wealth Management Group sold out of Halozyme (HALO) in Q1 2026, closing a stake of 77 shares — an estimated $5.18K sold.

Vermillion & White Wealth Management Group first reported a position in HALO in Q1 2025 and held it in 4 quarters. The position peaked at $5.65K in Q3 2025. 636 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Vermillion & White Wealth Management Group reported no remaining Halozyme position as of Q1 2026 after selling out during the quarter.
  • Vermillion & White Wealth Management Group sold 77 Halozyme shares in Q1 2026, an estimated $5.18K.
  • Vermillion & White Wealth Management Group first reported a position in Halozyme in Q1 2025 and held it in 4 quarters.
  • Vermillion & White Wealth Management Group's Halozyme position peaked at $5.65K in Q3 2025.
  • 636 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Vermillion & White Wealth Management Group's 13F filing for Q1 2026, filed 14 May 2026.